HOME >> BIOLOGY >> NEWS
Obesity, kidney genetics, erectile dysfunction among highlighted research at APS Meeting

September 22, 2003 (Bethesda, MD) Our heart, blood pressure and kidneys are essential for life, and the healthy interplay among them is key to good health. But high blood pressure (hypertension) can make the heart and blood vessels work harder and stresses the kidneys, which leads to a variety of cardiovascular and kidney diseases.

African-Americans are known to have disproportionately higher rates of elevated blood pressure compared to the rest of the U.S. population. These higher blood pressure rates also cause a number of kidney related health problems. Genetics may be the reason African-Americans aged 25-44 are 20 times more likely than their white counterparts to develop hypertension-related kidney failure.

Every body issues instructions to the heart, the blood vessels and the kidneys about what to do. Our individual genetic code, the individual proteins that create the genes, and the external environment in which we live combine to shape the instructions. Understanding the mechanisms dictating how these factors operate individually -- and their interplay among one another -- is the focus of research that will ultimately improve our understanding of human health and disease.

It is also the purpose of the upcoming fall meeting of the American Physiological Society (APS) (http://www.the-aps.org), being held October 1-4, 2003 at the Radisson Riverfront Hotel, Augusta, GA Research highlights of the meeting, entitled, Understanding Renal and Cardiovascular Function Through Physiological Genomics, include:

HEALTH AND RACE
Racial Differences in Stress-Induced Salt Sensitivity and Resulting Blood Pressure Load Researchers have tested their hypothesis that stress is a contributing factor to African-American health status through an effect on the kidneys via pressure natriuresis (the excretion of sodium in urine, usually in excessive amounts). They report on their protocol involvi
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-967-2751
American Physiological Society
23-Sep-2003


Page: 1 2 3 4

Related biology news :

1. Iron can have negative side effects on people with kidney disease
2. Newly grown kidneys can sustain life in rats
3. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
4. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
5. Patients give nod to kidney dialysis at home
6. Portable kidney dialysis machine developed
7. Early identification of kidney disease cost-effective only when directed at high-risk patients
8. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
9. Severe kidney disease in blacks linked to genes on two chromosomes
10. Sugar coupled to protein causes kidneys to save water
11. Molecule found to be critical for kidney development

Post Your Comments:
(Date:11/21/2014)... REDMOND, Wash. , Nov. 20, 2014 ... access for the Internet of Things (IoT), today announced ... position of chief operating officer. Previously a strategic advisor ... marketing, finance, and operations. Mr. Traynor is based out ... . He reports to Chris Muench , ...
(Date:11/18/2014)... 17, 2014 The Parenteral Drug Association (PDA) today ... will speak and at least seven more will participate in ... Omni Shoreham Hotel in Washington D.C. , ... have significant support from the regulatory agencies in ... in our effort to help advance the use of ...
(Date:11/11/2014)... , Nov. 11, 2014  Forensicon, Inc., a ... firm, is pleased to announce the promotion of ... Director of Digital Forensics. In Schiff,s new role as ... the team of digital forensics examiners and provide leadership ... Photo - http://photos.prnewswire.com/prnh/20141110/157719 ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
(Date:12/13/2014)... December 13, 2014 The “Global ... major market drivers, threats, opportunities, and challenges. , ... three major players, namely, Thermo Fisher Scientific, Inc. ... These players jointly accounted for approximately ~65% of ... , Full Copy for This Report @ ...
(Date:12/13/2014)... 13, 2014 QuickSTAT is making significant ... Cold Chain capabilities, and is delighted to announce the ... to serve Life Science clients in the region. , ... controlled-ambient warehouse, will provide 24/7 transportation and logistics services, ... drugs, patient-clinical specimens, API, following IATA rules and EU ...
(Date:12/13/2014)... Dec. 11, 2014 Research and Markets ... of the "Glucose Sensors: the Next Generation" ... http://photos.prnewswire.com/prnh/20130307/600769 The convergence ... is giving hope for a better future to ... that can measure glucose levels accurately and reliably ...
(Date:12/13/2014)... RARITAN, N.J. and SAN ANTONIO ... Development, LLC (Janssen) today announced the presentation of data ... the Phase 3 EPO-ANE-3010 study evaluating epoetin alfa plus ... treat anemia in patients with metastatic breast cancer receiving ... primary objective, which was to rule out a 15 ...
Breaking Biology Technology:Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 2Synthetic Biology Market to HIt $5.6304 Billion by 2018 - New Research Report by MarketsandMakets 3Quick Opens Office in France to Serve Life Science Community In France and Neighboring French-Speaking Countries 2Glucose Sensors: the Next Generation 2Glucose Sensors: the Next Generation 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 4Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 5Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 6Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 7Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 8Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 9Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 10Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 11Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 12
Cached News: